After a decade of scant gains, some investors are now piling into pharmaceuticals as a combination of high yields and attractive valuations draw managers in, but is this the start of a decade-long move up?
The Liontrust Income fund, headed up by Gary West and James Inglis-Jones, has reversed its focus on the UK in favour of a global mandate to tap into a larger universe of dividend paying stocks.
Fund group CEOs have blamed the impact of RDR for a sharp divergence between UK fund sales and those elsewhere in the world at the start of 2013.
Hermes' marketing director Rob Page is leaving the firm to join Henderson Global Investors, Investment Week can reveal.
Liontrust has scrapped rebates on its successful UK Smaller Companies fund, run by managers Anthony Cross and Julian Fosh, as it moves to premium price the product.
Liontrust doubled its assets under management to £3bn in the last 12 months as the takeover of Walker Crips and a sharp rise in inflows boosted the business.
As advisers digest last week's revelation that top UK fund manager Richard Buxton is to exit Schroders after more than a decade at the group, attention is now turning to where to invest next.